Also, pDCs stimulated with agonists for TLR7 and 9 upregulated the surface expression of TRAIL in a type I IFN-dependent manner, causing the lysis of Jurkat cells and melanoma cell lines SKMel2 and WM793 [244]. This evidence concerns the gene TLR7 and melanoma.